Yves Blériot

Deciphering minimal antigenic epitopes associated with Burkholderia pseudomallei and Burkholderia mallei lipopolysaccharide O-antigens

Marielle Tamigney Kenfack, Marcelina Mazur, Teerapat Nualnoi et al. · Nature Communications · 2017 · 43 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

Selective trihydroxyazepane NagZ inhibitors increase sensitivity of Pseudomonas aeruginosa to β-lactams

Martine Mondon, Soo Hur, Grishma Vadlamani et al. · Chemical Communications · 2013 · 41 citations

Life Sciences, Medicinal Chemistry, Pharmacology +17

<i>Burkholderia pseudomallei</i> Capsular Polysaccharide Recognition by a Monoclonal Antibody Reveals Key Details toward a Biodefense Vaccine and Diagnostics against Melioidosis

Roberta Marchetti, Michael J. Dillon, Mary N. Burtnick et al. · ACS Chemical Biology · 2015 · 38 citations

Pharmacy, Infectious Diseases, Molecular Biology +17

Cyclodextrin tetraplexes: first syntheses and potential as cross-linking agent

Thomas Lecourt, Yves Blériot, Rachel Auzély‐Velty et al. · Chemical Communications · 2010 · 20 citations

Natural Sciences, Chemistry, Medicinal Chemistry +8

Conformational flexibility of the glycosidase NagZ allows it to bind structurally diverse inhibitors to suppress β‐lactam antibiotic resistance

Grishma Vadlamani, Keith A. Stubbs, Jérôme Désiré et al. · Protein Science · 2017 · 20 citations · Full text

Life Sciences, Biochemistry, Microbiology +17